Page last updated: 2024-11-03

propranolol and Buphthalmos

propranolol has been researched along with Buphthalmos in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research Excerpts

ExcerptRelevanceReference
"The main purpose of this study was to describe a unique case of retro-orbital infantile hemangioma (IH) simulating a congenital glaucoma requiring prompt management with systemic propranolol."3.91Secondary Congenital Glaucoma Associated With Retro-orbital Infantile Hemangioma: A Masquerade Syndrome. ( Beylerian, M; Dambricourt, L; Denis, D; Matonti, F; Ramtohul, P, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ramtohul, P1
Beylerian, M1
Dambricourt, L1
Matonti, F1
Denis, D1

Other Studies

1 other study available for propranolol and Buphthalmos

ArticleYear
Secondary Congenital Glaucoma Associated With Retro-orbital Infantile Hemangioma: A Masquerade Syndrome.
    Journal of glaucoma, 2019, Volume: 28, Issue:6

    Topics: Diagnosis, Differential; Female; Glaucoma; Hemangioma; Humans; Hydrophthalmos; Infant; Intraocular P

2019